[1] Parker-Athill EC,Ehrhart J,Tan J,et al.Cytokine correlations in youth with tic disorders[J].J Child Adolesc Psychopharmacol,2015,25(1):86-92. [2] 卫利,王素梅,崔霞,等.多发性抽动症动物模型的比较与评价[J].中华行为医学与脑科学杂志,2012,21(2):187-189. [3] Canal CE,Morgan D.Head-switch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine:a comprehensive history,a re-evaluation of mechanisms,and its utility as a model[J].Drug Test Anal,2012,4(7-8):556-576. [4] Diamond BI,Reyes MG,Borison R.A new animal model for Tourette Syndrome[J].Adv Neurol,1982,35(2):221-225. [5] Kadasah SA,Mutairy AA,Siddiquei M,et al.Pentoxifylline attenuates iminodipropionitrile-induced behavioral abnomalities in rats[J].Behav Pharmacol,2009,20(4):356-360. [6] Taylor JR,Morshed SA,Parveen S,et al.An animal model of Tourette's syndrome[J].Am J Psychiatry,2002,159(4):657-660. [7] Nestler EJ,Tallman JF.AMP-dependent protein kinase activity in the rat locus coeruleus[J].Mol Pharmacol,1988,33(2):127-132. [8] Ibrahim KE,Khan HA,Omer FA.Histological insights in iminodipropionitrile-induced toxicity in rats[J].Exp Toxicol Pathol,2014,66(2-3):89-96. [9] Hayslett RL,Tizabi Y.Effects of donepezil,nicotine and haloperidol on the central serotonergic system in mice:implications for Tourette's syndrome[J].Pharmacol Biochem Behav,2005,81(4):879-886. [10] Cáceda R,Binder EB,Kinkead B,et al.The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion[J].Schizophr Res,2012,136(1-3):88-95. [11] Swerdlow NR,Krupiin AS,Bongiovanni MJ,et al.Heritable differences in the dopaminergic regulation of behavior in rats:relationship to D2-like receptor-G-protein-function[J].Neuropsychopharmachology,2006,31(4):721-729. [12] Shprecher DR,Schrock L,Himle M.Neurobehavioral aspects,pathophysiology,and management of Tourette syndrome[J].Curr Opin Neurol,2014,27(4):484-492. [13] Cannon E,Silburn P,Coyne T,et al.Deep brain stimulation of anteromedial globus pallidus interna for severe Tourette's syndrome[J].Am J Psychiatr,2012,169(8):860-866. [14] Duits A,Ackermans L,Cath D,et al.Unfavourable outcome of deep brain stimulation in a Tourette patient with severe comorbidity[J].Eur Child Adolesc Psychiatry,2012,21(9):529-531. [15] Leckman JF,Bloch MH,Smith ME,et,al.Neurobiological Substrates of Tourette's Disorder[J].Child Adolesc Psychopharmacol,2010,20(4):237-247. [16] Beier H,Elvén B.Tourette syndrome-in the borderland between neurology and psychiatry[J].Lakartidningen,2014,111(39):1657-1659. [17] Yoon DY,Gause CD,Leckman JF,et al.Frontal dopaminergic abnormality in Tourette syndrome:a postmortem analysis[J].Neurol Sci,2007,255(1-2):50-56. [18] 隆红艳,张骠.静安口服液对小儿多发性抽动症模型大鼠脑内多巴胺转运体分布的影响[J].中国实验方剂学杂志,2011,17(21):181-183. [19] McGrath MJ,Campbell KM,Parks CR,et a1.Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model comorbid Tourette's syndrome and obsessive-compulsive disorder[J].Brain Res,2000,877(1):23-30. [20] Felling RJ,Singer HS.Neurobiology of tourette syndrome:current status and need for-further investigation[J].Neurosci,2011,31(35):12387-12395. [21] Macrì S,Onori MP,Laviola G.Theoretical and practical considerations behind the use of laboratory animals for the study of Tourette syndrome[J].Neurosci Biobehav Rev,2013,37(6):1085-1100. |